ckd and semaglutide Long-term kidney outcomes of in obesity cardiovascular disease in the SELECT trial Semaglutide just got FDA-approved for

These results are consistent with a study finding lower cerebrospinal fluid (CSF) levels of DSIP in hospitalized patients with schizophrenia or depressive disorders [13]

If your PCN or practice needs support with obesity medicine workload, medication reviews or prescribing safety, we can help.

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies

The best GLP-1 friendly snacks share two characteristics

Dry is essential

If your GP does not have much experience with GLP-1 treatment, you can ask for a referral to a specialist or a weight management clinic